Pharmaceutical companies aiming to develop innovative new therapies and treatments face many challenges. Without proper processes and systems in place, it is very difficult to replicate successful results, mitigate failures, reduce product variability and ultimately deliver a new therapy to market. Having competent control and visibility over each step of the development process, from early stage ideation through scale up and production, is becoming increasingly important in modern laboratory facilities. This includes not only having total control over laboratory operations but also the proper documentation to prove process control for quality and regulatory compliance. A critical factor in optimizing efficiencies and control is to ensure that a life science laboratory is both safe and predictable. Safeguarding a state-of-the-art, innovation-based laboratory is no easy task and requires foresight, experience, and attention to detail. With this in mind, many pharmaceutical companies opt for a proactive, rather than reactive, approach to monitoring and protecting valuable life science facilities, assets and equipment.